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ABSTRACT
Background: Although several studies have described effects of dexmedeto-
idine on peripheral nerve blocks, to date there is limited knowledge available on the
mpact of dexmedetomidine adjunct to levobupivacaine in axillary brachial plexus
lock.
Objective: In this study, we aimed to investigate the effects of adding
exmedetomidine to levobupivacaine for an axillary brachial plexus block.
Methods: A total of 64 patients of American Society of Anesthesiologists
hysical status I/II scheduled to undergo forearm and hand surgery, in which an
xillary block was used, were enrolled. The patients were randomly divided into 2
roups: in group L patients (n  32), an axillary block was performed with 39 mL
evobupivacaine 5% plus 1 mL of isotonic sodium chloride. In group D patients (n
2), an axillary block was performed with 39 mL levobupivacaine 5% and 1 mL
exmedetomidine 1 g/kg1 plus isotonic sodium chloride. Demographic data,
mean arterial pressure (MAP), heart rate (HR), peripheral oxygen saturation (SpO2),
sensory and motor block onset times and block durations, time to first analgesic use,
total analgesic need, intraoperative verbal analog scale, postoperative visual analog
scale (VAS) data, and side effects were recorded for each patient.
Results: There were no significant differences in patient and surgery charac-
teristics between the 2 groups. Sensory block onset time was shorter in group D (P 
0.05). Sensory and motor block duration and time to first analgesic use were
significantly longer in group D (P 0.05), and the total need for analgesics was lower
in group D (P  0.05). Intraoperative 5- and 10-minute verbal analog scale values
and postoperative VAS value at 12 hours were significantly lower in group D (P 
0.05). Intraoperative MAP and HR values, except at 5 minutes and postoperatively
at 10 and 30 minutes and 1 and 2 hours, were significantly lower in group D (P 
0.01). Bradycardia, hypotension, hypoxemia, nausea, vomiting, and any other side
effects were not seen in any patients.
Conclusions: It was concluded in our study that adding dexmedetomidine to
xillary brachial plexus block shortens sensory block onset time, increases the sensory
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Current Therapeutic Researchand motor block duration and time to first analgesic use, and decreases total analgesic
use with no side effects. ClinicalTrials.gov identifier ISRCTN67622282. (Curr Ther
es Clin Exp. 2012;73:103–111) © 2012 Elsevier HS Journals, Inc. All rights
eserved.
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INTRODUCTION
Levobupivacaine is the S()-enantiomer of racemic bupivacaine; it has less cardio-
toxicity compared with bupivacaine,1,2 and its pharmacology and duration of anes-
thesia are similar to those of bupivacaine.2
Numerous studies have been conducted on the use of local anesthetic agents with
djuvants such as clonidine (a partial 2-adrenoreceptor agonist) and tramadol
3,4 for
brachial plexus block to improve the quality and duration of anesthesia, and these
tudies have shown that the adjuvants may prolong anesthesia and analgesia. More-
ver, dexmedetomidine is a 2-receptor agonist that has more selectivity than
clonidine and has analgesic and sedative properties.5,6 Although several studies have
described the effects of dexmedetomidine on neuroaxial and peripheral nerve
blocks,7–9 to date, there is only 1 study available, performed by Esmaoglu et al,10 on
he effect of adding dexmedetomidine to levobupivacaine for an axillary brachial
lexus block. In view of the idea that decreasing the dose of dexmedetomidine may
elp to reduce side effects such as bradycardia and hypotension, we wanted to evaluate
he effect of dexmedetomidine at a lower dose than that used in their study and the
esults. We think that more studies on this issue are needed.
In this study, we aimed to investigate the effects of adding dexmedetomidine to
evobupivacaine for an axillary brachial plexus block. The primary outcome of our
tudy was the duration of sensory block, and the secondary outcome was postoperative
nalgesia. We hypothesized that adding dexmedetomidine will prolong the duration
f anesthesia and analgesia with a shorter onset time.
METHODS
The study was performed after ethics committee approval (no. 2007-4/4) and written
informed consent of the patients were received between December 2008 and Sep-
tember 2009. In this study, 64 patients with American Society of Anesthesiologists
(ASA) physical status I/II who were scheduled to undergo forearm and hand surgery
in which an axillary block was to be used were enrolled in this prospective, double-
blind, controlled trial. Patients with a history of cardiac, respiratory, hepatic, or renal
failure; those with coagulopathy; those with an allergy to amide local anesthetics;
those receiving adrenoreceptor agonist or antagonist therapy or long-term analgesic
therapy; and pregnant women were excluded from the study.
The patients were randomly divided into 2 groups: group L (n  32): levobupi-
acaine (Chirocaine 5 mg/mL; Abbott Laboratories, Istanbul, Turkey) with isotonic
odium chloride. Group D (n  32): levobupivacaine and dexmedetomidine (Prece-
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K. Kaygusuz et al.dex 200 g/2 mL; Hospira, Illinois) with isotonic sodium chloride. The randomiza-
tion was achieved by random number table using a sealed envelope technique. The
drug solutions were prepared by an anesthesiologist who was not involved in the
study.
The patients were monitored for their mean arterial blood pressure (MAP), heart
rate (HR), and peripheral oxygen saturation (SpO2) in the operating room before the
lock, and baseline values were recorded. All patients were not given any premedi-
ation. After insertion of a 20-gauge intravenous catheter in a peripheral vein in the
ontralateral arm, the axillary block was performed with the patient in the supine
osition with the upper arm in 90° abduction and the elbow in 110° flexion. During
he application, a nerve stimulator (Stimuplex; B. Braun, Melsungen, Germany) was
sed for the nerve localization. For the block, a 22-gauge, 50-mm stimulating needle
Stimuplex D; B. Braun Melsungen AG, Tokyo, Japan) was used. The stimulator was
djusted to 1.0-mA, 2-Hz, 0.1-ms parameters at the beginning of the procedure. The
ocation of the needle was considered adequate when an output current of 0.5 mA
aused a slight distal motor response. After the localization of radial, ulnar, median,
nd musculocutaneous nerves, group L patients (n  32) were given a total 40-mL
olution consisting of 39 mL levobupivacaine 0.5% with 1 mL of isotonic sodium
hloride solution. Group D patients (n  32) were given a total 40-mL solution
onsisting of 39 mL levobupivacaine 0.5% with a 1-mL volume of 1 g/kg1
dexmedetomidine plus isotonic sodium chloride solution in a double-blind mode. We
used a multistimulation technique in all the patients of both groups. The anesthetic
mixture (10 mL for each nerve  40 mL) was injected after identifying the radial,
ulnar, median, and musculocutaneous nerves in each patient. During injection,
negative aspiration was performed every 3.0 to 4.0 mL to avoid intravascular injec-
tion. If there was any blockade failure in a nerve distribution region, even if the block
was adequate for the surgery, the patients were excluded from the study. All axillary
brachial plexus blocks were performed by the same anesthesiologist.
Sensory and motor blocks of the median, radial, ulnar, and musculocutaneous
nerves and HR, MAP, and SpO2 values were recorded 5, 10, 20, 30, 60, and 80
inutes after the block and 10 and 30 minutes and 1, 2, 4, 6, and 12 hours after the
nd of the surgery. Sensory block of each nerve was assessed by a pinprick test. Sensory
lock was rated by the patient on a verbal analog scale from 100 (normal sensation)
o 0 (no sensation). Motor block was evaluated by thumb adduction (ulnar nerve),
humb abduction (radial nerve), flexion of the elbow and pronation of forearm
musculocutaneous), and thumb opposition (median nerve). Motor block evaluation
as performed using a modification of the Levvott rating scale from 6 (normal
uscular force) to 0 (complete paralysis).
The onset time of the sensory and motor block was defined as the time between the
nd of the local anesthetic injection and no response to the pinprick test and complete
aralysis. The duration of the sensory block was considered as the time interval
etween complete sensory block and the first postoperative pain, and the duration of
otor block was defined as the time interval between the complete paralysis and
omplete recovery of motor function. The time to first analgesic use and total need for
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Current Therapeutic Researchanalgesics were recorded during the first postoperative 12 hours. Postoperative pain
levels were evaluated by a 10-cm visual analog scale (VAS) from 0 (no pain) to 10
(severe pain). Hypotension (a 20% decrease from the baseline value), bradycardia
(HR  50 beats/min), hypoxemia (SpO2 90%), and nausea and vomiting occur-
ences were also recorded. If there were hypotension, bradycardia, and hypoxemia, we
lanned to administer ephedrine 10 mg IV, atropine 1mg IV, and 4 to 5 L/h1 O2
inhalation therapy, respectively. If VAS values were 4, the patient was given
iclofenac 75 mg IM. The anesthesiologist who evaluated the block responses and the
atients were blinded to the solution used.
We performed a pilot study of 10 patients (5 in each group) before the present
tudy and calculated that a sample size of 32 patients in each group would be
ufficient for at least a 1-hour difference in duration of sensory block. Statistical power
as calculated to be 0.96 for the sensory block period as   0.05 and   0.04.
Statistical analysis was performed with SPSS software version 14.0 (SSPS Inc.,
hicago, Illinois). The age, height, weight, surgery time, onset time, and duration of
ensory and motor block data were evaluated by the Kolmogorov-Smirnov test. Age,
eight, weight, surgery time, onset time, and duration of sensory and motor block
ere compared between the groups using an independent 2-sample t test. Sex and
SA physical status were compared using the 2 test. P  0.05 was considered
significant.
RESULTS
Four patients (2 from each group) were excluded from the study because of inadequate
block. There were no significant differences in patient and surgery characteristics
between the 2 groups (Table I).
Sensory block onset time was shorter in group D (P  0.05). Sensory and motor
lock duration and time to first analgesic use were significantly longer in group D
P  0.01), and the total need for analgesics was also lower in group D (P  0.05)
Table I. Patient and surgical characteristics.
Group L
(n  30)
Group D
(n  30)
Sex (female/male) 11/19 12/18
Age, y 38.75 (9.31) 35.85 (12.57)
Height, cm 165.22 (7.32) 168.36 (8.14)
Weight, kg 70.35 (5.92) 73.75 (8.11)
ASA status, I/II 16/14 15/15
Duration of surgery, min 59.50 (22.73) 62.52 (26.34)
Values shown for age, height, weight, and duration of surgery values are mean (SD), and the values
shown for sex and American Society of Anesthesiologists (ASA) class are the number of patients.Table II). Intraoperative 5- and 10-minute verbal analog scale values for sensory
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VAS value was also lower in group D (P  0.05).
Except at 5 minutes, intraoperative MAP and HR values were significantly lower in
group D (P 0.01) (Figures 1 and 2). Postoperative MAP and HR values at 10 and 30
minutes and 1 and 2 hours were lower in group D (P  0.01) (Figures 3 and 4).
However, no patient experienced an episode of hypotension, bradycardia, or hypoxemia
that required treatment during either the intraoperative or postoperative period. Intra-
operative SpO2 values were not different between the 2 groups. Side effects such as nausea
and vomiting were not seen in any patients in the 2 groups.
DISCUSSION
The hypothesis of this study was that adding 1 g/kg1 dexmedetomidine to 39 mL
levobupivacaine 0.5% for an axillary brachial plexus block shortens the sensory block
Table II. Block characteristics.
Group L
(n  30)
Group D
(n  30)
Sensory block onset time, min 10.75 (2.55) 7.75 (2.22)*
Motor block onset time, min 15.75 (4.06) 14.25 (3.92)
Duration of sensory block, min 664.62 (61.70) 924.15 (78.27)*
Duration of motor block, min 540.14 (54.25) 804.27 (71.33)*
Time to first analgesic, min 736.80 (45.31) 1279.54 (138.42)*
Total analgesic need 11 0*
All values except total analgesic need data are mean (SD). The value shown for total analgesic need data
is the number of patients.
*P  0.05 compared with group L.
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Figure 1. Intraoperative mean arterial pressure (MAP) values. *P < 0.05 compared with
group L.
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and decreases the total analgesic requirement with no side effects.
To date, there has been an increasing use of some adjuncts (eg, opioids, 2-
adrenoreceptor agonists) to local anesthetics to improve the block quality in periph-
eral nerve blocks. It was suggested in some studies that the addition of 2 agonists
to local anesthetics in peripheral nerve blocks improved the block quality and
extended the block duration.4,9–12 The mechanism of action of 2-adrenoceptor
agonists in peripheral nerve blocks is not understood fully. The most probable
mechanisms include vasoconstriction, central analgesia, and anti-inflammatory ef-
fects.9–12 Conversely, in some previous studies,13–16 in which clonidine was used as
he adjuvant, no prolongation or improvement was reported.
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Figure 2. Intraoperative heart rate (HR) values. *P < 0.05 compared with group L.
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Figure 3. Postoperative mean arterial pressure (MAP) values. *P < 0.05 compared with
group L.
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evaluated the effects of dexmedetomidine on neuroaxial and peripheral nerve
blocks,7,17,18 and dexmedetomidine was reported to be safe and effective in these
studies. In a study that compared the effects of adding either clonidine or dexme-
detomidine to lidocaine during a Bier block, it was found that adding dexmedeto-
midine improved the quality of anesthesia and analgesia more than the addition of
clonidine.19 Kol et al20 compared the effects of adding dexmedetomidine and lor-
oxicam to prilocaine in a Bier block and reported that adding dexmedetomidine had
hortened the sensory block onset time and prolonged the sensory block recovery time
ore than lornoxicam. In 2 other studies, a dexmedetomidine–lidocaine mixture was
sed to provide a Bier block and was found to improve the quality of anesthesia and
educe postoperative analgesic requirement.17,18
Bajwa et al21 had compared dexmedetomidine and clonidine in epidural anesthesia
and concluded that dexmedetomidine is a better neuraxial adjuvant compared with
clonidine for providing an early onset of sensory analgesia and prolonged postoper-
ative analgesia.
To date, several studies evaluated the effects of clonidine in axillary brachial plexus
blocks11–16 and found that clonidine had an improving effect on quality and duration
of anesthesia. Our knowledge is limited to only 1 study performed by Esmaoglu et
al10 to evaluate the effects of dexmedetomidine in axillary brachial plexus blocks.
smaoglu et al divided 60 patients who had been scheduled to undergo forearm and
and surgery using an axillary block into 2 groups. They administered 0.5% 40 mL
evobupivacaine plus 1 mL saline solution in 1 group and 0.5% 40 mL levobupiva-
aine plus 100 g dexmedetomidine in other group. Their study differs from our
study in the dexmedetomidine dose that we used (1 g/kg1 dexmedetomidine).
Esmaoglu et al found that adding dexmedetomidine to levobupivacaine for an axillary
brachial plexus block shortens both the sensory and motor block onset time, extends
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Figure 4. Postoperative heart rate (HR) values. *P < 0.05 compared with group L.the block duration, and the analgesia period. There was no shortening of the motor
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indicated that dexmedetomidine may lead to bradycardia. Bradycardia did not occur
in our study, which is another point on which our study differs. We thought that the
different results of the study by Esmaoglu et al, such as the shortened motor block
onset time and the occurrence of bradycardia, in contrast to those of our study, could
be related to their use of the higher dexmedetomidine dose of 100 g in all patients.
CONCLUSIONS
We conclude that adding dexmedetomidine for an axillary brachial plexus block at a
dose of 1 g/kg1 improves block quality by shortening the sensory block onset
time, increasing the sensory and motor block duration, and increasing the interval to
the first analgesic use with no side effects. We also suggest that adding dexmedeto-
midine to axillary brachial plexus block may decrease postoperative total analgesic
use, even if it has clinically minimal relevance because we evaluated the analgesic
consumption by using only a single dose of a nonsteroidal anti-inflammatory drug.
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